Na/Ca exchange (NCX) regulates cardiac Ca and contractility. NCX function during the cardiac cycle is determined by intracellular [Ca] and [Na] ([Ca] i , and [Na] i ) and membrane potential (E m ), which all change in human heart failure (HF). Therefore, changes in NCX function may contribute to abnormal Ca regulation in human HF. Methods and Results-We assessed the cellular bases of differences in NCX function in ventricular myocytes from failing (F) and nonfailing (NF) human hearts. Allosteric activation of NCX by [Ca] i was comparable in F and NF myocytes (K 1/2 ϭ150Ϯ31 nmol/L, nϭ7). The steady-state relation between [Ca] i and NCX current (I NCX ) was used to infer the local submembrane [Ca] i ([Ca] sm ) that is sensed by NCX dynamically during the action potential (AP) and Ca transient (37°C). This involved "tail" I NCX measurement during abrupt repolarization of APs and Ca transients, where peak inward I NCX indicates [Ca] sm . This allows inference of the direction of Ca transport by the NCX during the AP. In NF myocytes, NCX extrudes Ca for most of the AP. Three factors shift the direction of NCX-mediated Ca transport (to favor more Ca influx) in F versus NF myocytes, as follows: (1) reduced [Ca] sm , (2) prolonged AP duration, and (3) elevated [Na] i . Conclusions-These results show that Ca entry through NCX may limit systolic dysfunction due to reduced sarcoplasmic reticulum Ca stores in HF but could contribute to slow decay of the [Ca] i transient and to diastolic dysfunction.
S arcolemmal Na/Ca exchange (NCX) competes with sarcoplasmic reticulum (SR) Ca-ATPase in causing systolic Ca transient decline and relaxation. 1 In many hypertrophy and heart failure (HF) models, NCX expression is increased, [2] [3] [4] [5] [6] and this could enhance the contribution of NCX to twitch relaxation. Because NCX and SR Ca-ATPase compete during [Ca] i decline, reduced SR Ca-ATPase function indirectly favors greater NCX contribution to relaxation (even without altered NCX expression or properties). 1, 7 In addition, NCX function is strongly influenced by [Ca] i , [Na] i , and membrane potential (E m ), all of which change in HF. Typically in HF (versus control), Ca transients are smaller in amplitude and decline more slowly, 8, 9 [Na] i is higher, 10, 11 and action potential duration (APD) is prolonged. 4, 12, 13 These would all reduce Ca extrusion through NCX during the cardiac cycle and bias NCX toward Ca influx. In addition, local submembrane [Ca] i ([Ca] sm ) sensed by NCX during normal Ca transients is higher than global [Ca] i measured by fluorescent Ca indicators. 14, 15 Thus, quantitative analysis of NCX function is imperative to understand how NCX functions during action potentials (AP) in human HF.
When E m is negative to the NCX reversal potential (E NCX ϭ3E Na Ϫ2E Ca ), Ca extrusion is favored (inward NCX current, I NCX ), whereas E m above E NCX favors Ca entry (outward I NCX ). As [Ca] i , [Ca] sm , and E m change during the AP, net I NCX changes dynamically. Low [Ca] i , high [Na] i , and long APD favor Ca entry through NCX. Our goal here is to evaluate how NCX functions during the AP in ventricular myocytes from failing (F) and nonfailing (NF) human hearts.
We show that Ca entry through NCX is readily demonstrable, characterize allosteric NCX activation by [Ca] i , determine [Ca] sm during normal AP, and infer the actual Ca flux through NCX during the AP. In NF myocytes, NCX primarily extrudes Ca throughout the cardiac cycle. However, in typical F myocytes, there is substantial Ca entry through NCX during the AP (explaining the slowly rising [Ca] i seen in many F myocytes). Additionally, we demonstrate how important thermodynamic determinants are (versus number of NCX molecules) to NCX behavior.
Methods

Cell Isolation, Electrophysiology, and [Ca] i Measurement
Myocytes were isolated from F and NF human hearts as described previously and were from the same 11 F and 7 NF patients (mean ejection fractions were 17.5Ϯ4.9% and 54.1Ϯ4.6% by echocardiography). 7 E m and current were controlled and recorded using discontinuous, single-electrode voltage clamp at 37°C. Ca signals were recorded with the use of fluo-3.
Solutions Used for Electrophysiological Recording
Pipettes (1 to 3 M⍀) were filled with the following (in mmol/L): 130 cesium aspartate, 20 tetraethylammonium chloride, 1 MgCl 2 , 10 HEPES, 2.5 NaCl, 5 Na 2 ATP, and 0.1 potassium-fluo-3, pH 7.2, using CsOH at 37°C. Total [Na] (12.5 mmol/L) was based on human myocyte estimates. 10 Seals were attained in solution (normal Tyrode) containing the following (in mmol/L): 150 NaCl, 5.4 KCl, 10 glucose, 5 HEPES, and 1 MgCl 2 , 1 CaCl 2 , with pH 7.4 at 37°C using NaOH. After patch rupture, 30 mol/L niflumate and 3 mmol/L 4-aminopyridine were added (to block Ca-activated chloride and potassium currents), and CsCl replaced KCl.
Allosteric Ca Activation of I NCX
Cells were pretreated with 1 mol/L thapsigargin to block SR Ca-ATPase and 20 mol/L nifedipine-blocked L-type Ca channels. E m was initially Ϫ100 mV to keep [Ca] i low but then oscillated between ϩ100 mV and Ϫ100 mV to drive Ca flux through I NCX . 16 
Time Course of [Ca] sm During AP
Nifedipine and thapsigargin were omitted, allowing normal excitation contraction coupling (ECC). A typical AP, recorded with physiological solutions at 1 Hz (37°C) from a F human myocyte, was used as an AP-clamp waveform. AP clamps were interrupted at 10 to 500 ms by repolarization to Ϫ70 mV, yielding tail I NCX . Capacitative current and I Ca were subtracted, 15 leaving only I NCX , which was used to infer [Ca] i sensed by NCX ([Ca] sm ).
Steady-State I NCX Versus [Ca] i
The steady-state relation between [Ca] i and I NCX is described in the Equation. 15 The three factors are allosteric regulation by [Ca] i , which is not transported (Allo), competitive binding of Na and Ca as substrates (Bind) and the effects of E m (Elect). The latter two combined give an electrochemical term. K m values are intracellular (i) and extracellular (o) Na and Ca dissociation constants. K mCaAct ϭ150 nmol was determined here; other constants are as in Reference 15. Maximal I NCX flux (V max ) was determined for each cell by using the measured [Ca] i dependence of I NCX (V max ϭ8.8Ϯ3.6 and 6.8Ϯ1.8 A/F for NF and F), consistent with unaltered NCX mRNA and [Ca] i dependence in these F hearts. 7
Results
Ca Fluxes Through NCX
Slow depolarizing voltage ramps from Ϫ100 mV ( Figure 1A) show Ca entry through I Ca and I NCX (with SR function blocked).
[Ca] i increased biphasically with depolarization (see also rate of [Ca] i rise, d[Ca] i /dt). Figure 1B shows that d[Ca] i /dt rises, with a hump between Ϫ25 and ϩ30 mV reflecting Ca entry through I Ca , and rises again at more positive E m (as Ca entry through I Ca declines and that through I NCX rises). Moreover, d[Ca] i /dt attributable to I NCX reaches levels comparable to that through I Ca and drives [Ca] i considerably higher. These Ca fluxes emphasize that substantial Ca entry can occur through I NCX (and was similar in F or NF human myocytes).
Repolarization promotes Ca removal by NCX, shown three ways in Figure 1C . One is based on d[Ca] i /dt (after correcting for cytosolic Ca buffering). 7 The solid red curve is measured I NCX (corrected for surface-to-volume ratioϭ13 pF/pL). 7 The dashed curve is based on the Equation (using V max ϭ5.1 A/F, pipette [Na] i ϭ12.5 mmol/L, and the measured [Ca] i and E m ). This demonstrates that [Ca] i decline correlates well with measured I NCX and also that the Equation describes well the [Ca] i dependence of I NCX in human ventricular myocytes.
During the cardiac cycle, E m , [Ca] i , and [Na] i all influence I NCX activity electrochemically (and [Ca] i activates NCX allosterically), even at constant NCX expression. Figure 2 illustrates the independent effects of E m , [Na] i , and [Ca] i on outward I NCX , using the Equation. As E m increases from 0 mV to ϩ100 mV, outward I NCX increases dramatically ( Figure  2A ), corresponding with the progressive rise in d[Ca] i /dt at positive E m in Figure 1A . Figure 2B shows how increasing [Na] i promotes outward I NCX . Alterations in [Ca] i have complex effects on outward I NCX because the electrochemical and allosteric effects are directionally opposite ( Figure 2C ). As [Ca] i rises, outward I NCX at ϩ20 mV (Ca influx) first increases as a result of allosteric Ca activation, but at higher [Ca] i the electrochemical effect becomes more dominant and outward I NCX decreases. For inward I NCX (E m ϭϪ80 mV), higher [Ca] i increases both allosteric and electrochemical factors.
Allosteric Activation of I NCX
We measured allosteric activation of I NCX in intact human myocytes (with other transporters and channels blocked), 16 using E m to control I NCX direction ( Figure 3B and 3C). Outward I NCX at ϩ100 mV drives Ca entry, whereas inward I NCX extrudes Ca at Ϫ100 mV, creating [Ca] i oscillations ( Figure 3A ). During each pulse, I NCX and [Ca] i values were taken to create Figure 3D . Inward I NCX at Ϫ100 mV increases as [Ca] i rises, as a result of both allosteric Ca activation and increased thermodynamic driving force. Outward I NCX at ϩ100 mV decreases with rising [Ca] i , (reduced driving force), but the increase in outward I NCX with [Ca] i must be attributed to allosteric activation. Figure 3D shows mean fits of the Equation to both the inward and outward I NCX . There was no major difference detected between F and NF human myocytes, and the mean allosteric K mCaAct was 150Ϯ31 nmol/L.
Submembrane [Ca] and I NCX During AP
Fluorescent indicators do not sense local [Ca] sm near the NCX. This is a minor complication for Figure 3 but more problematic when I Ca and SR release are functional, and [Ca] sm may far exceed bulk [Ca] i . 15 High [Ca] sm biases I NCX in the inward direction versus that expected from [Ca] i . Using our novel approach developed in rabbit myocytes, 15 we assessed [Ca] sm in human F and NF myocytes. This allows more direct evaluation of NCX function during the AP.
Peak twitch [Ca] i is lower in F versus NF human myocytes. 7 In Figure 4A , the AP was interrupted at different times and I NCX tails were measured at Ϫ70 mV ( Figure 4B ). Here, I Ca , SR Ca transport, and ECC are fully functional. Conditioning pulses before each test AP ensured steady-state SR Ca loading. We plot measured I NCX versus [Ca] i ( Figure 4D ) and compared initial I NCX with the steady-state relation (fitting the Equation to the late [Ca] i decline; thick line in Figure 4D ). Figure 5D shows I NCX , based on [Ca] sm and E m during the AP (using the Equation) .
In NF human myocytes, I NCX is inward for almost the entire AP, except very briefly early in the AP. The first inward current hump is driven largely by high [Ca] sm , whereas the later inward hump is driven mainly by repolarization. Integrated Ca flux by I NCX (Figure 5E ) reaches Ͼ30 mol Ca/L cytosol. We calculate that to reach the observed peak [Ca] i requires 120 mol Ca/L cytosol (based on our cytosolic Ca buffering measurement). 7 This implies that NCX extrudes 25% of activator Ca during the cardiac cycle in NF human myocytes (matching values from simpler analysis of [Ca] i decline). 7 In HF, there is substantial outward I NCX during the AP ( Figure  5D ). This is largely due to lower peak [Ca] i , since the AP-clamp was identical and 12.5 mmol/L [Na] i was used for F and NF in both the pipette and calculations. Thus, the low [Ca] i and [Ca] sm cause sufficient outward shift in I NCX to bring in substantial Ca during the AP. The integral in Figure 5E peaks at ϩ12 mol Ca/L cytosol before repolarization causes I NCX to switch direc-tions and extrude Ca. This suggests significant Ca entry during the AP in HF, which can contribute to the Ca transient and contraction (thereby limiting the negative inotropic impact of reduced SR Ca content). 7 The mean rate of Ca influx through I NCX during 100 to 300 ms of the HF AP ( Figure 5D ) is 36 mol/L cytosol/s. This is almost identical to the gain in Ca based on the slow rise in [Ca] i during this time in Figure 5B (35 mol/L cytosol/s; accounting for cytosolic buffering). We conclude that this slowly rising [Ca] i during the HF AP is largely due to Ca entry through NCX. Figure 5E shows that by end-diastole in HF (1 second at 1 Hz), NCX has extruded a net 20 mol/L cytosol. Thus, in the HF case, NCX can remove the Ca that entered through NCX and I Ca . At a heart rate of 1.5 Hz, Ca would tend to accumulate in F myocytes, but APD also shortens, reducing Ca entry and allowing more time for diastolic Ca extrusion through I NCX . Figure 5 is appropriate for myocytes studied here (with some cellular dialysis), but in NF versus F myocytes, the APD is shorter and [Na] i is lower. 7, 10, 11 Figure 6A extends our analysis to simulate NF conditions, with shorter AP duration (by 100 ms), different [Na] i values, Ca transient as in Figure  5 (but with 10% faster [Ca] i decline), and at [Ca] o ϭ1.25 mmol/L (physiological free [Ca] o ). 17 The rate and integral of SR Ca pumping is also shown. For NF cells ([Na] i ϭ8 to 10 mmol/L), Ca transport through NCX is similar to that shown in Figure 5 , consistent with [Na] i in NF cells. 10 In F myocytes (versus NF), there is more Ca influx through NCX at any [Na] i . This effect is more pronounced at the elevated [Na] i (Ϸ12 mmol/L) in HF. 10, 11 In the F simulations at 12 mmol/L [Na] i , NCX barely extrudes the Ca that entered during the AP and at 1 second has only extruded 5 mol/L of the Ca that enters through I Ca (net extrusion does not reach 13 mol/L cytosol until 1.9 seconds). At 1 Hz, this would cause cellular Ca gain, larger Ca transients, and consequently a greater Ca extrusion, until a new steady state is attained (where Ca influx and efflux are balanced during the cardiac cycle). Ca extrusion rate through NCX is relatively low during the AP versus SR Ca pump, but on repolarization the Ca flux rates are more comparable.
Discussion
We quantitatively characterized NCX function during APs in human ventricular myocytes (F and NF) for the first time. Our major findings are the following. (1) 
Allosteric Regulation of Human NCX by [Ca]
Estimates of Ca affinity of the allosteric NCX site vary from K mCaAct of 22 to 125 nmol/L in intact myocytes 18, 16 to 300 to 600 nmol/L in giant excised patches. 19 The higher excised patch values might reflect loss of some unknown NCX regulator. Although our protocol measures physiologically relevant NCX activation by Ca, K mCaAct could be slightly underestimated because we use [Ca] i versus [Ca] sm (but this is a minor issue here versus during SR Ca release). Nevertheless, we conclude that as [Ca] i increases in human myocytes, NCX activates much like ferret, canine, 16 and rabbit NCX (Weber and Bers, unpublished observation, 2002) , but unlike mouse NCX, which displays weak allosteric Ca regulation at physiological [Ca] i . 16 Furthermore, we did not detect a difference in allosteric Ca activation between F and NF myocytes, consistent with unaltered [Ca] i dependence of I NCX in Reference 7.
Allosteric Ca activation augments inward and outward I NCX . As [Ca] i rises during an AP, Ca activation will activate NCX molecules regardless of the direction favored thermodynamically. This could enhance Ca influx early in the AP (and later in HF), but as [Ca] i (and [Ca] sm ) increase, NCX switches direction to Ca efflux. At this time, inward I NCX will be stimulated by allosteric activation, thermodynamic driving force, and higher substrate concentration. This accelerates Ca extrusion through NCX. As [Ca] i approaches diastolic levels, NCX partially deactivates, helping to prevent [Ca] i from going too low. This K mCaAct (Ϸ150 nmol/L) may help to set diastolic [Ca] i near to but below the threshold for contractile and ryanodine receptor activation and allow NCX to optimally stabilize resting [Ca] i . This K mCaAct may also keep NCX partially active for the next beat.
[Ca] sm Sensed by NCX
During SR Ca release, inward I NCX rises more rapidly than bulk [Ca] i . 14, 20, 21 However, one cannot simply block I NCX (or other currents) to measure physiologically relevant I NCX because it is interdependent on I Ca and SR Ca release. In our quantitative approach developed in rabbit ventricular myocytes, 15 (and earlier) , causing those NCX molecules to shift to Ca extrusion even earlier during the AP. Thus, the submembrane space here is not anatomically defined but is functionally defined by average NCX behavior.
In F and NF human ventricular myocytes (37°C), we found that even with unaltered NCX expression or properties, 7 changes in [Ca] i , [Na] i , and E m characteristic of HF alter I NCX during the AP ( Figure 5 ). Our results with NF human and rabbit ventricular myocytes 15 are similar. That is, the rapid [Ca] sm rise causes I NCX to be almost entirely inward (extruding Ca) throughout the cardiac cycle. In contrast, I NCX differs in F human myocytes, which exhibit a small early peak [Ca] i and slowly rising [Ca] i during the AP. The lower [Ca] sm during the AP plateau causes substantial Ca entry through I NCX . This functional difference between F and NF human myocytes is further magnified when we account for the longer AP duration and elevated [Na] i seen in F versus NF myocytes ( Figure 6 ). Previous simulations of I NCX in HF (human and rabbit) suggest such an outward shift in I NCX , 11, 22 but in this study we demonstrate this directly. Indeed, Despa et al 11 compared how altered [Ca] i , [Na] i , and APD in rabbit HF are expected to influence Ca entry through I NCX . Higher [Na] i was the most effective, but all would contribute in HF.
Not all F human myocytes show the prominent and typical phenotype in Figure 5B . About 50% of F cells exhibit various intermediate phenotypes between that in Figure 5B and the NF phenotype (although overall mean Ca transients were clearly smaller and slower in F). 7 Thus, there is cellular heterogeneity, but in many F human ventricular myocytes there is clearly sufficient Ca entry through NCX during the AP to boost [Ca] i . This Ca entry may contribute directly to support contraction by enhancing Ca binding to myofilaments and limiting the reduction in SR Ca load. If this shift in NCX fluxes did not occur in HF, the degree of systolic dysfunction would be even worse. Similar qualitative conclusions were made for a nonischemic rabbit HF model, but [Ca] sm was not measured. 4, 11 That is, reduced Ca transients, elevated [Na] i , and prolonged APD caused similar shifts in I NCX during the AP. Thus, these conclusions have broad impact with respect to excitationcontraction coupling in HF (although rat and mouse models that lack AP plateau may differ).
We previously considered possible sources of error in this method, 15, 23 but these effects are small and occur very early during the AP and so do not affect our conclusions.
Balance of Ca Fluxes During the Cardiac Cycle
Many studies report elevated NCX expression in HF, [2] [3] [4] [5] 24 which could partly compensate for lowered SR Ca pump activity 5 in preserving relaxation rate and diastolic function. However, either reduced SR Ca pump function or increased Ca extrusion through NCX shift Ca from the SR out of the cell, unloading the SR. [2] [3] [4] [5] 25, 26 In the human hearts studied here, the [Ca] i dependence of I NCX was unaltered in F versus NF, so the reduced SR Ca-pump function is more important in reducing SR Ca content. 7 Notably, SR Ca content is reduced despite the shift toward outward I NCX during the AP. Indeed, unaltered I NCX properties do not preclude major alterations in NCX function. In F versus NF, lower [Ca] sm allows NCX-mediated Ca influx during the AP, but slowed [Ca] sm decline drives an increase in NCX-mediated Ca efflux during diastole ( Figure 5D ).
In F, there is less SR Ca release (due to lower SR Ca content) and greater Ca influx (due to less Ca-dependent I Ca inactivation, longer APD, and Ca entry through I NCX ). Thus, there must also be less SR Ca uptake and greater Ca extrusion through NCX during the cardiac cycle. This must be true, regardless of details. Although most aspects of our quantitative analysis agree with former work, net extrusion of Ͼ30 mol/L Ca during a cardiac cycle implies an equal amount of Ca entry, presumably through I Ca . This is somewhat higher than expected for integrated I Ca influx during the AP 1 but is consistent with 25% of the 120 mol/L cytosol of activator Ca crossing the sarcolemma. It is possible that we underestimate how completely NCX shuts off during diastole. Thus, although the present quantitative analysis is valuable, further refinement should be sought.
In conclusion, I NCX reverses physiologically, making knowledge of [Ca] i , [Na] i , and E m essential in understanding I NCX . Thermodynamic factors are as important as protein expression levels. In NF human myocytes, Ca extrusion through I NCX occurs almost throughout the cardiac cycle, whereas in F myocytes, substantial Ca entry occurs through I NCX during the AP. This Ca entry depends on lower peak [Ca] i , higher [Na] i , and prolonged APD in F myocytes. This may limit the systolic dysfunction observed in HF but could also slow relaxation and worsen diastolic dysfunction.
